SNY Stock Summary and Trading Ideas (Sanofi - American Depositary Shares | NASDAQ:SNY)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.

As of June 18, 2026, SNY stock price declined to $42.38 with 2,924,894 million shares trading.

SNY has a beta of 0.75, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.11 to the broad based SPY ETF.

SNY has a market cap of $101.45 billion. This is considered a Large Cap stock.

Last quarter Sanofi - American Depositary Shares reported $12 billion in Revenue and $1.10 earnings per share. This beat revenue expectation by $317 million and exceeded earnings estimates by $.04.

In the last 3 years, SNY traded as high as $60.12 and as low as $41.86.

The top ETF exchange traded funds that SNY belongs to (by Net Assets): PVAL, PPH, FVD, FENI, AVDE.

SNY has underperformed the market in the last year with a price return of -5.9% while the SPY ETF gained +26.9%. SNY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.5% and -4.5%, respectively, while the SPY returned +13.5% and -1.1%, respectively.

SNY support price is $41.82 and resistance is $43.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.